Care is organised in such a way that, depending on the patient’s clinical condition, at least two individual or group treatment sequences are provided each working day in the case of full hospitalisation, or each time a patient is admitted on a part-time basis.
In addition to the coordinating doctor provided for in article D. 6124-177-69, the registrant appoints an additional coordinating doctor specialising in haematology or with proven training or experience in onco-haematology.
The authorisation holder is able to ensure the continuation and monitoring of chemotherapy treatment, under the conditions set out in article R. 6123-90-1.
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Resources
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Useful links
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.
All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.
